DS-8201

Hengrui SHR-A1811: Soaring Higher on the Shoulders of DS-8201

by
Hengrui SHR-A1811: Soaring Higher on the Shoulders of DS-8201

Focused and dedicated, stepping onto the international stage Written by|Little Medicine Monster The latest generation of anti-HER-2 ADC drug developed by Hengrui, SHR-A1811, is often jokingly referred to as the domestic alternative to DS-8201 due to its similar structure. However, strength will eliminate all rumors. Results from early clinical studies released by AACR this year … Read more

Exciting News: DS-8201 Brings New Hope for HER2 Positive Breast Cancer Patients!

by
Exciting News: DS-8201 Brings New Hope for HER2 Positive Breast Cancer Patients!

With the advancement of breast cancer treatment, there are increasingly more life-saving drugs available for patients. The emergence of new treatment methods is like a relay race, passing on the hope of life, even in the face of recurrence and metastasis, it is no longer a dead end. In the past, anti-HER2 treatments saved countless … Read more